United States Dental Implants & Abutments Outlook to 2025
All the vital news, analysis, and commentary curated by our industry experts.
“What is covered in the report about the “United States Dental Implants & Abutments Market”?
GlobalData’s “United States Dental Implants & Abutments Market Outlook to 2025” report is a comprehensive databook report, covering key market data on the United States Dental Implants & Abutments market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Dental Abutments and Dental Implants.
The United States Dental Implants & Abutments Market report provides key information and data on
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2018 company share and distribution share data for Dental Implants & Abutments market.
• Global corporate-level profiles of key companies operating within the United States Dental Implants & Abutments Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
United States Dental Implants & Abutments is segmented as follows:
• Dental Abutments
• Dental Implants
Key Reasons to Purchase
The United States Dental Implants & Abutments Market report helps you to develop
• Business strategies by identifying the key market segments poised for strong growth in the future.
• Market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the market.
• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
Key companies covered in the “United States Dental Implants & Abutments Market Outlook to 2025” report
• Nobel Biocare Services AG
• Straumann Holding AG
• Dentsply Sirona Inc
The GlobalData Differentiation
Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.
The data and analysis within this report are driven by GlobalData Medical Equipment (GDME) databases. GlobalData Medical Equipment database gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:
• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports
• 64,000+ medical equipment company profiles
• 5,600+ company profiles of medical equipment manufacturers in China and India
• 2,200+ company profiles of medical equipment manufacturers in Japan
• 1,200+ companies’ revenue splits and market shares
• 1,600+ quarterly and annual medical equipment company financials
• 850+ medical equipment company SWOTs
• 28,000+ pipeline product profiles
• 56,400+ marketed product profiles
• 47,000+ clinical trials
• 41,500+ trial investigators
• 7,000+ reports on companies with products in development
• 44,000+ deals in the medical equipment industry
• 1,100+ surgical and diagnostic procedures by therapy area
• 50+ key healthcare indicators by country
• 431,000+ Themes Content Items
• 600+ Influencers
• 1,900+ Analysts & Researchers
• 0.5m+ Community Members
• 141,000+ Macroeconomic Indicators
• 1,013,000+ City Indicators
For more information or to receive a free demonstration of the service, please visit:
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.
Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Dental Implants & Abutments Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Dental Implants & Abutments Market, United States 8
3.1 Dental Implants & Abutments Market, United States, Revenue ($m), 2015-2025 8
3.1.1 Dental Abutments Market, United States, Revenue ($m), by Segment, 2015-2025 10
3.1.2 Dental Implants Market, United States, Revenue ($m), by Segment, 2015-2025 13
3.2 Dental Implants & Abutments Market, United States, Volume (Units), 2015-2025 15
3.2.1 Dental Abutments Market, United States, Volume (Units), by Segment, 2015-2025 17
3.2.2 Dental Implants Market, United States, Volume (Units), by Segment, 2015-2025 20
3.3 Dental Implants & Abutments Market, United States, Average Price ($), 2015-2025 22
3.4 Dental Implants & Abutments Market, United States, Distribution Share by Revenue ($m), 2018 24
3.5 Dental Implants & Abutments Market, United States, Company Share by Revenue ($m), 2018 25
4 Overview of Key Companies in United States, Dental Implants & Abutments Market 27
4.1 Nobel Biocare Services AG 27
4.1.1 Company Overview 27
4.2 Straumann Holding AG 27
4.2.1 Company Overview 27
4.3 Dentsply Sirona Inc 27
4.3.1 Company Overview 27
4.4 Zimmer Biomet Holdings Inc 28
4.4.1 Company Overview 28
4.5 Osstem Implant Co Ltd 28
4.5.1 Company Overview 28
4.6 KYOCERA Medical Corp 28
4.6.1 Company Overview 28
5 Financial Deals Landscape 29
5.1 Acquisition 29
5.1.1 Avalign Technologies Acquires Integrated Medical Solutions 29
5.2 Debt Offerings 30
5.2.1 Stryker Raises USD826.2 Million in Public Offering of 1% Notes Due 2031 30
5.2.2 Stryker Raises USD881.3 Million in Public Offering of
0.75% Notes Due 2029 32
5.2.3 Stryker Raises USD936.4 Million in Public Offering of
0.25% Notes Due 2024 34
5.2.4 Zimmer Biomet Prices Public Offering of
1.164% Notes Due 2027 for USD553 Million 36
5.3 Equity Offerings 38
5.3.1 Envista Holdings Raise USD588.9 Million in IPO of Shares 38
5.3.2 Sintx Technologies to Raise USD1.6 Million in Public Offering of Shares 40
5.3.3 Zimmer Biomet Plans to Raise Funds through Public Offering of Securities 41
5.3.4 Stryker Plans to Raise Funds through Public Offering of Securities 42
5.4 Venture Financing 43
5.4.1 Zuga Medical Raises Funds through Series B+ Financing 43
5.4.2 Genesis Innovation Invests in HAPPE Spine 44
6 Recent Developments 45
6.1 Corporate Communications 45
6.1.1 Sep 25, 2019: Dentsply Sirona announces appointment of Janet Vergis as new Board Member 45
6.1.2 Aug 29, 2019: Straumann Group announces two appointments to its Executive Management team 45
6.1.3 Aug 22, 2019: Henry Schein builds more than 27,000 ‘Comfort Kits’ for people fighting cancer in the second annual ‘We Care Global Challenge’ 46
6.1.4 Aug 12, 2019: Stryker announces commercial structure realignment 47
6.1.5 Jul 25, 2019: Dentsply Sirona announces a new leader for its North American commercial business 47
6.1.6 Jul 08, 2019: Dentsply Sirona announces appointment of Jorge M. Gomez as Chief Financial Officer 47
6.1.7 Jul 05, 2019: Eric Bruno to lead North America commercial business at Dentsply Sirona 48
6.1.8 Jun 19, 2019: Zimmer Biomet announces chief financial officer transition plan 48
6.1.9 May 08, 2019: Dr. Cord F. Stahler is the new Chief Technology Officer at Dentsply Sirona 49
6.1.10 Apr 15, 2019: SINTX Technologies hires strategic VP 49
6.1.11 Mar 27, 2019: Stryker announces new Vice President, chief legal officer 50
6.2 Financial Announcements 50
6.2.1 Nov 07, 2019: Dentsply Sirona reports third quarter 2019 financial performance 50
6.2.2 Nov 05, 2019: Henry Schein reports record third quarter 2019 financial results from continuing operations 51
6.2.3 Nov 05, 2019: Zimmer Biomet announces third quarter 2019 financial results 53
6.2.4 Oct 29, 2019: Stryker reports third quarter 2019 operating results 54
6.2.5 Oct 24, 2019: Envista reports third quarter 2019 results 55
6.2.6 Sep 25, 2019: ThermoGenesis reports performance evaluations of X-Series Cell Processing Devices 56
6.2.7 Sep 11, 2019: Daxor to exhibit at the 23rd Annual Scientific Meeting of the Heart Failure Society of America 57
6.2.8 Aug 14, 2019: Straumann Group: Strong momentum continues as first-half organic revenue climbs 16% and core EBIT margin reaches 28% 58
6.2.9 Aug 06, 2019: Henry Schein reports record second quarter 2019 financial results from continuing operations 62
6.2.10 Aug 02, 2019: Dentsply Sirona reports strong second quarter 2019 results 64
6.2.11 Jul 26, 2019: Zimmer Biomet announces second quarter 2019 financial results 65
6.2.12 Jul 25, 2019: Stryker reports second quarter 2019 operating results 65
6.2.13 Jul 09, 2019: Carestream shows Advanced Imaging Software, Flexible Portfolio of Mobile Imaging Systems at AHRA 66
6.2.14 Jul 03, 2019: MedTech Innovator announces OncoRes Medical as 2019 Value Award Winner at WSGR Device Conference 69
6.2.15 May 07, 2019: Henry Schein announces first quarter 2019 financial results 70
6.2.16 May 03, 2019: Dentsply Sirona reports solid first quarter 2019 results 72
6.2.17 Apr 30, 2019: Promising start to the year with 17% organic growth in first quarter 73
6.2.18 Apr 26, 2019: Zimmer Biomet announces first quarter 2019 financial results 74
6.2.19 Apr 23, 2019: Stryker announces first quarter 2019 operating results 75
6.2.20 Apr 03, 2019: MediciNova receives notice of allowance for new patent covering mn-001 for the treatment of hypertriglyceridemia, hypercholesterolemia, and hyperlipoproteinemia in China 76
6.2.21 Mar 18, 2019: Clara AI lets every radiologist teach their own AI 76
6.2.22 Mar 01, 2019: Dentsply Sirona reports preliminary fourth quarter and full year 2018 results 77
6.2.23 Feb 20, 2019: Henry Schein reports record fourth quarter and full year 2018 financial results 78
6.2.24 Feb 19, 2019: Straumann posts strong Q4, lifting full-year organic revenue growth to 19% as underlying EBITDA margin reaches 30% 80
6.2.25 Feb 01, 2019: Zimmer Biomet announces fourth quarter and full-year 2018 financial results 84
6.2.26 Jan 29, 2019: Stryker reports 2018 results and 2019 outlook 85
6.3 Government and Public Interest 86
6.3.1 Jun 21, 2019: Statement from Jeff Shuren, M.D., J.D., director of the FDA's Center for Devices and Radiological Health, on agency's efforts to increase transparency in medical device reporting 86
6.4 Legal And Regulatory 87
6.4.1 Oct 16, 2019: U.S. Federal Trade Commission Judge dismisses claims against Henry Schein 87
6.4.2 Sep 26, 2019: TSO3 announces receipt of final Court approval for plan of arrangement with Stryker 87
6.4.3 May 23, 2019: Dentsply Sirona Board Approves Relocation of Headquarters to Charlotte N.C. and Announces CFO Transition PLan 87
6.5 Other Significant Developments 88
6.5.1 Oct 02, 2019: Dr. Joseph Kravitz on Innovations in Dental Implants 88
6.5.2 Jul 29, 2019: SINTX Technologies provides business update 88
6.5.3 Jul 11, 2019: Dr. Joseph Kravitz successfully treated thousands of patients with 3 minute implant 89
6.5.4 Jun 25, 2019: Award-Winning Maryland Dentist Dr. Joseph Kravitz continues to pioneer new treatment approaches for dental patients 90
6.5.5 Jun 14, 2019: Stryker to invest €200m in RD&I projects in Ireland 90
6.5.6 Feb 28, 2019: BIOLASE appoints Sinclair Dental, the fastest growing full-service dental supply company in Canada, as the exclusive distributor and representative for the sales, service and support of BIOLASE's products 91
6.6 Product News 91
6.6.1 Mar 12, 2019: Henry Schein to showcase comprehensive portfolio of solutions for Health Care Professionals at the 38th International Dental Show 91
6.7 Strategy And Business Planning 92
6.7.1 Nov 05, 2019: Stryker signs agreement to acquire Wright Medical for $5.4bn 92
6.7.2 May 24, 2019: Menicon announces launch of Menicon Bloom Myopia Control Management System 93
7 Appendix 94
7.1 Research Methodology 95
7.1.1 Coverage 95
7.1.2 Secondary Research 95
7.1.3 Primary Research 96
7.1.4 Market Modeling and Forecasting 97
7.1.5 Company Share Analysis 98
7.1.6 Distribution Share Analysis 99
7.1.7 Benchmarking 99
7.2 GlobalData Consulting 99
7.3 Contact Us 100
7.4 Disclaimer 100
Frequently asked questions
Undecided about purchasing this report?Enquire Before Buying
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Business Intelligence & Marketing Manager, SAL Heavy Lift
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
Market Analyst & Management, Liebherr-Werk
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Head of Key Accounts, Saab AB
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Marketing Intelligence Manager, Portugal Foods
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
Head of Customer Insight and Research, Standard Chartered
Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.
I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.
I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.
Head of Consumer Sensory Insights, Givaudan
“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.
Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”
Senior Account Manager, TSYS
GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.
I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.
One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.